Scarica l'app Stockscreener
15.37
0.71%
-0.11
Pre-mercato:
15.13
-0.24
-1.56%
Precedente Chiudi:
$15.48
Aprire:
$15.49
Volume 24 ore:
3.87M
Relative Volume:
1.14
Capitalizzazione di mercato:
$3.67B
Reddito:
$474.17M
Utile/perdita netta:
$208.93M
Rapporto P/E:
18.10
EPS:
0.8493
Flusso di cassa netto:
$65.61M
1 W Prestazione:
-1.47%
1M Prestazione:
+4.84%
6M Prestazione:
-34.65%
1 anno Prestazione:
-20.65%
Intervallo 1D:
$15.10
$15.68
Intervallo di 1 settimana:
$15.07
$15.76
Portata 52W:
$13.82
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Nome
Adma Biologics Inc
Settore
Industria
Telefono
(201) 478-5552
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Confronta ADMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
15.37 | 3.69B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-19 | Ripresa | Raymond James | Strong Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Iniziato | Jefferies | Buy |
| 2019-04-15 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-07 | Ripresa | H.C. Wainwright | Buy |
| 2017-12-11 | Reiterato | Maxim Group | Buy |
| 2017-11-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2016-08-01 | Downgrade | Maxim Group | Buy → Hold |
| 2016-07-25 | Reiterato | Maxim Group | Buy |
| 2015-05-13 | Reiterato | Maxim Group | Buy |
| 2014-12-08 | Iniziato | Oppenheimer | Outperform |
| 2014-12-01 | Reiterato | Maxim Group | Buy |
Mostra tutto
Adma Biologics Inc Borsa (ADMA) Ultime notizie
ADMA Biologics Inc (ADMA) Q3 2025: Everything You Need to Know A - GuruFocus
Can ADMA Biologics Inc. stock attract ESG capital inflowsRate Hike & Risk Managed Investment Entry Signals - newser.com
Risk adjusted return profile for ADMA Biologics Inc. analyzed2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com
Y Intercept Hong Kong Ltd Buys 38,809 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Applying Wyckoff theory to ADMA Biologics Inc. stockJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
ADMA Biologics (ADMA): Evaluating Valuation After Major Institutional Exit by Palisades Investment Partners - Yahoo Finance
Building trade automation scripts for ADMA Biologics Inc.Market Movers & Verified Technical Signals - newser.com
ADMA Biologics (ADMA) to Release Quarterly Earnings on Thursday - MarketBeat
Will ADMA Biologics Inc. stock keep outperforming rivalsTreasury Yields & Weekly Hot Stock Watchlists - newser.com
ADMA Biologics Inc Stock Analysis and ForecastSector Performance Drivers & Free Take Advantage Of Momentum - earlytimes.in
Will ADMA Biologics Inc. stock continue dividend increasesTrade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com
ADMA Biologics, Inc. (ADMA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
ADMA Biologics Inc (ADMA) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - sharewise.com
ADMA Biologics Inc (ADMA) Stock forecasts - Yahoo! Finance UK
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times
ADMA Biologics (Nasdaq: ADMA) sets Nov. 5 call at 4:30 p.m. ET for third-quarter results - Stock Titan
Is ADMA Biologics Stock Trading At A Bargain? - Trefis
Signal Recap: Why ADMA Biologics Inc. stock is a must watch in 2025Earnings Performance Report & Verified Swing Trading Watchlist - fcp.pa.gov.br
Peregrine Capital Management LLC Acquires 53,515 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Will ADMA Biologics Inc. stock outperform international peersExit Point & Risk Controlled Swing Trade Alerts - fcp.pa.gov.br
Risk Check: Why ADMA Biologics Inc. stock is a must watch in 2025 - Fundação Cultural do Pará
Analyst Upgrade: Will ADMA Biologics Inc. stock continue dividend increasesPortfolio Value Summary & Real-Time Volume Spike Alerts - fcp.pa.gov.br
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - sharewise.com
ADMA Biologics Adjusts Valuation Amid Strong Financial Performance and Growth Metrics - Markets Mojo
Is ADMA Biologics Inc a good long term investmentEarnings Date Calendar & Low Entry Investment Ideas - earlytimes.in
ADMA Biologics (ADMA): Assessing Valuation After Q2 Earnings Miss and Upgraded Financial Outlook - Sahm
Comparing ADMA Biologics Inc. in custom built stock radarsTrade Exit Summary & Trade Opportunity Analysis - newser.com
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):